tiprankstipranks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX

BioRestorative Therapies (BRTX) Financial Statements

157 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently ―. The company's EPS TTM is $-1.491; its P/E ratio is -1.11; BioRestorative Therapies is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 35.00K$ 30.70K$ 64.50K$ 31.30K$ 3.70K
Gross Profit$ 35.00K$ 30.70K$ 64.50K$ 31.30K$ 3.70K
EBIT$ -2.36M$ -3.02M$ -3.08M$ 5.77M$ -4.56M
EBITDA$ -2.32M$ -2.98M$ -3.04M$ 5.80M$ -4.53M
Net Income Common Stockholders$ -3.93M$ -2.93M$ -2.98M$ 5.75M$ -4.35M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 16.42M$ 12.24M$ 11.62M$ 12.37M$ 14.75M
Total Assets$ 17.95M$ 13.80M$ 13.30M$ 14.08M$ 16.43M
Total Debt$ 123.54K$ 198.72K$ 234.06K$ 268.36K$ 301.64K
Net Debt$ -16.29M$ -12.04M$ -11.38M$ -12.11M$ -14.45M
Total Liabilities$ 3.45M$ 975.03K$ 896.43K$ 593.93K$ 602.62K
Stockholders Equity$ 14.50M$ 12.83M$ 12.40M$ 13.49M$ 15.83M
Cash Flow-
Free Cash Flow$ -2.30M$ -1.19M$ -1.23M$ -2.36M$ -1.79M
Operating Cash Flow$ -2.30M$ -1.18M$ -1.20M$ -2.30M$ -1.57M
Investing Cash Flow$ -4.93M$ -23.06K$ 665.80K$ 2.51M$ -3.32M
Financing Cash Flow$ 7.52M$ 1.85M$ 411.70K--
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis